GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lin BioScience Inc (ROCO:6696) » Definitions » Enterprise Value

Lin BioScience (ROCO:6696) Enterprise Value : NT$3,701.23 Mil (As of Jun. 09, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Lin BioScience Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Lin BioScience's Enterprise Value is NT$3,701.23 Mil. Lin BioScience's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-1,089.33 Mil. Therefore, Lin BioScience's EV-to-EBIT ratio for today is -3.40.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Lin BioScience's Enterprise Value is NT$3,701.23 Mil. Lin BioScience's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-1,071.40 Mil. Therefore, Lin BioScience's EV-to-EBITDA ratio for today is -3.45.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Lin BioScience's Enterprise Value is NT$3,701.23 Mil. Lin BioScience's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was NT$0.00 Mil. Therefore, Lin BioScience's EV-to-Revenue ratio for today is .


Lin BioScience Enterprise Value Historical Data

The historical data trend for Lin BioScience's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lin BioScience Enterprise Value Chart

Lin BioScience Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial 1,707.13 5,897.55 11,973.45 11,450.48 7,024.25

Lin BioScience Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,973.45 12,948.49 11,450.48 8,041.99 7,024.25

Competitive Comparison of Lin BioScience's Enterprise Value

For the Biotechnology subindustry, Lin BioScience's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lin BioScience's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lin BioScience's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Lin BioScience's Enterprise Value falls into.



Lin BioScience Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Lin BioScience's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Lin BioScience's Enterprise Value for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lin BioScience  (ROCO:6696) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Lin BioScience's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3701.234/-1089.33
=-3.40

Lin BioScience's current Enterprise Value is NT$3,701.23 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Lin BioScience's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-1,089.33 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Lin BioScience's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=3701.234/-1071.403
=-3.45

Lin BioScience's current Enterprise Value is NT$3,701.23 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Lin BioScience's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-1,071.40 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Lin BioScience's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3701.234/0
=

Lin BioScience's current Enterprise Value is NT$3,701.23 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Lin BioScience's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lin BioScience Enterprise Value Related Terms

Thank you for viewing the detailed overview of Lin BioScience's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Lin BioScience (ROCO:6696) Business Description

Traded in Other Exchanges
N/A
Address
Zhongxiao East Road, 12th Floor, No. 68, Section 5, Xinyi District, Taipei City, TWN, 110
Lin BioScience Inc is a drug development company. It specializes in therapies for diseases with unmet medical needs. Its novel pipeline consists of first-in-class drugs aimed at treating life-threatening or disabling diseases in oncology, ophthalmology, cardiovascular, and metabolic disease.

Lin BioScience (ROCO:6696) Headlines

No Headlines